Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Accessible Treatment
20%
African American
20%
Aggregation-prone Protein
20%
AI Classifiers
20%
Alcohol
20%
Alcohol Effects
20%
Alpha-synuclein (α-syn)
20%
Array Comparative Genomic Hybridization (aCGH)
20%
Artificial Intelligence
20%
Co-pathology
20%
Conflict Resolution
20%
Copy number Variation
20%
Deep Brain Stimulation
31%
Dementia
20%
Disease Heterogeneity
20%
Dystonia
20%
Genome-wide Association Study
20%
Idiopathic Parkinson's Disease
20%
Juvenile Myoclonic Epilepsy
20%
Juvenile Myoclonus Epilepsy
20%
Lewy Pathology
20%
Long Non-coding RNA (LncRNA)
20%
Matching Task
41%
Meta-analysis
20%
Mobility Metrics
20%
Motor Assessment
20%
Motor Outcome
20%
Motor Subtypes
26%
Movement Disorder Society
18%
Movement Disorders
29%
Myoclonic Seizures
20%
Neocortical
20%
Neurodegenerative Diseases
36%
NUcleic acid-Linked Immuno-Sandwich Assay (NULISA)
20%
Parkinson's Disease
100%
Parkinson's Disease Dementia
20%
Parkinson's Disease Risk
18%
Progressive Supranuclear Palsy
26%
Protein-based
20%
Protracted Course
20%
Rating Scale
18%
Seizure
26%
Sialidosis
20%
Stroop
41%
Subthalamic nucleus
20%
Task Effects
20%
Task Interference
20%
Treatment Options
20%
Unified Parkinson's Disease Rating Scale (UPDRS)
33%
Valproic Acid
20%
Neuroscience
Alzheimer's Disease
17%
Antiseizure Medication
15%
Artificial Intelligence
20%
Ataxia
5%
Autophagy
10%
Deep Brain Stimulation
26%
Dementia with Lewy Bodies
6%
Gait
9%
Genetics
7%
In Vitro
5%
Intravenous Immunoglobulin
20%
Lewy Body
20%
Long Non-Coding RNA
20%
Mass Spectrometry
5%
Myoclonic Seizure
20%
Neurodegenerative Disorder
36%
Nucleic Acid
20%
Oxidative Stress
5%
Parkinson's Disease
70%
Progressive Supranuclear Palsy
26%
Protein Aggregation
5%
Proteomics
5%
Sodium Oxybate
5%
Stem Cell
5%
Stereotypic Movement Disorder
25%
Subthalamic Nucleus
20%
Synuclein
20%
Transcriptomics
5%
Wearable Sensor
5%